CIHR Operating Grant: Addressing the Wider Health Impacts of COVID-19
Launched in early September, this funding opportunity seeks research proposals to address the gaps in knowledge about the wider impacts of the COVID-19 pandemic and response on the health and health care of people in Canada. Suspension/interruption of cancer screening is one of the research areas of focus.
The maximum amount per grant that can be requested for clinical trial research is $1,000,000 over 2 years; for other types of research, the maximum amount per grant is $500,000 over 2 years. Registration deadline is October 18, 2021. For more information, see https://www.researchnet-recherchenet.ca/rnr16/vwOpprtntyDtls.do?prog=3548&language=E.

CCRA welcomes Dr. Dajan O’Donnell to its Board as the representative for the Cancer Research Society, where he serves as the Director of Scientific Affairs and Partnerships. Dajan is a seasoned professional with recent experience at Exactis Innovation and a long tenure in the pharmaceutical industry. He has a PhD in neur...
Effective January 1, 2020, Dr. Don Desserud begins his term as the Patient/Family Representative on the CCRA Board. Dr. Desserud participated in the 2019 Patient Involvement in Cancer Research Project (PIP) and is a survivor of Non-Hodgkin Lymphoma.
Dr. Desserud is a Political Science professor and researcher at th...